Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System
Gastaldon, C., Raschi, E., Kane, J. M., Barbui, C., & Schoretsanitis, G. | Psychotherapy and psychosomatics | December 2020
The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats
Brandt, S. D., Walters, H. M., Partilla, J. S., Blough, B. E., Kavanagh, P. V., & Baumann, M. H. | Psychopharmacology | 01 September 2020
Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin
Dahmane, E., Hutson, P. R., & Gobburu, J. V. | Clinical Pharmacology in Drug Development | 06 April 2020
In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation.
Berquist, M. D., Leth-Petersen, S., Kristensen, J. L., & Fantegrossi, W. E. | Drug and Alcohol Dependence | 13 January 2020
Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species
Halberstadt, A. L., Chatha, M., Klein, A. K., Wallach, J., & Brandt, S. D. | Neuropharmacology | 7 January 2020
Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe
Miliano, C., Marti, M., Pintori, N., Castelli, M. P., Tirri, M., Arfè, R., & De Luca, M. A. | Frontiers in Pharmacology | 12 December 2019
Locomotor effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in mice: psychostimulant effects, stereotypy, and sensitization
Berquist, M. D., Leth-Petersen, S., Kristensen, J. L., & Fantegrossi, W. E. | Psychopharmacology | 15 Nov 2019
Metabolism of lysergic acid diethylamide (LSD): an update.
Libânio Osório Marta, R. F. | Drug metabolism reviews | 16 July 2019
Transformative Psychopharmacology: the Case of 5-Methoxy-N,N-Dimethyltryptamine
Jan M Keppel Hesselink | International Journal of Psychotherapy Practice and Research | 2 January 2019
DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens
Lakstygal, A., Kolesnikova, T., Khatsko, S., Zabegalov, K., Volgin, A., Demin, K., & Kalueff, A. | ACS chemical neuroscience | 19 December 2018
Pharmacokinetic And Pharmacodynamic Aspects Of Peyote And Mescaline: Clinical And Forensic Repercussions
Dinis-Oliveira, R. J., Pereira, C. L., & Da Silva, D. D | Current molecular pharmacology | 10 October 2018
Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions
Riva-Posse, P., Reiff, C. M., Edwards, J. A., Job, G. P., Galendez, G. C., Garlow, S. J., ... & McDonald, W. M. | Journal of affective disorders | 19 July 2018
Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine
Dunlap, L. E., Andrews, A. M., & Olson, D. E. | ACS chemical neuroscience | 12 July 2018
Cardiac arrest after ibogaine intoxication
Steinberg, C., & Deyell, M. W | Journal of arrhythmia | 12 June 2018
Key interindividual determinants in MDMA pharmacodynamics
Papaseit, E., Torrens, M., Pérez-Mañá, C., Muga, R., & Farré, M. | Expert opinion on drug metabolism & toxicology | 14 February 2018
Evaluating the abuse potential of psychedelic drugs for medical use in humans
Heal, D. J., Gosden, J., & Smith, S. L. | Neuropharmacology | 7 February 2018
Is LSD toxic?
Nichols, D. E., & Grob, C. S. | Forensic science international | 2 February 2018
Psychedelic Drugs in Biomedicine
Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. | Trends in Pharmacological Sciences | 22 September 2017
First Time View on Human Metabolome Changes after a Single Intake of 3,4-Methylenedioxymethamphetamine in Healthy Placebo-Controlled Subjects
Boxler, M. I., Liechti, M. E., Schmid, Y., Kraemer, T., & Steuer, A. E. | Journal of proteome research | 1 September 2017
MDA, MDMA and other mescaline-like substances in the US military’s search for a truth drug (1940s to 1960s)
Passie, T., & Benzenhöfer, U. | Drug testing and analysis | 29 August 2017
Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs
Hassan, Z., Bosch, O. G., Singh, D., Narayanan, S., Kasinather, B. V., Seifritz, E., ... & Müller, C. P. | Frontiers in psychiatry | 18 August 2017
Mushroom-Derived Indole Alkaloids
Homer, J. A., & Sperry, J. | Journal of Natural Products | 19 July 2017
First time view on human metabolome changes after a single intake of 3,4 methylenedioxymethamphetamine (MDMA) in healthy placebo-controlled subjects
Boxler, M. I., Liechti, M. E., Schmid, Y., Kraemer, T., & Steuer, A. E. | Journal of Proteome Research | 19 July 2017
Isolated non-cardiogenic pulmonary edema – A rare complication of MDMA toxicity
Haaland, A., Warman, E., Pushkar, I., Likourezos, A., & Friedman, M. S. | The American journal of emergency medicine | 27 June 2017
A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum
Li, S., Cheng, X., & Wang, C. | Journal of Ethnopharmacology | 5 May 2017